Related Experiment Video
Updated: Jul 12, 2026
07:08
Fractionation for Resolution of Soluble and Insoluble Huntingtin Species
Published on: February 27, 2018
9.6K
Curcumin Inhibits α-Synuclein Aggregation by Acting on Liquid-Liquid Phase Transition
Jian-Feng Li1, Zi-Qun Jiang1, Sen Cao1
1Institute of Ageing Research, School of Basic Medical Sciences, Hangzhou Normal University, 2318 Yuhangtang Road, Hangzhou 311121, China.
Foods (Basel, Switzerland)
|May 11, 2024
Summary
Curcumin inhibits Parkinson's disease pathology by preventing alpha-synuclein aggregation. This natural compound blocks early-stage liquid-liquid phase separation and oligomer formation, offering a potential therapeutic strategy.
Area of Science:
- Neuroscience
- Biochemistry
- Pharmacology
Background:
- Parkinson's disease (PD) is a neurodegenerative disorder associated with alpha-synuclein (α-Syn) aggregation.
- Curcumin, a compound from turmeric, shows therapeutic potential for PD, but its anti-amyloidogenic mechanisms are unclear.
Purpose of the Study:
- To investigate the anti-amyloidogenic mechanisms of curcumin in Parkinson's disease.
- To explore how curcumin affects alpha-synuclein liquid-liquid phase separation (LLPS) and subsequent aggregation.
Main Methods:
- Reconstruction of α-Syn liquid-liquid phase separation (LLPS) in vitro.
- Evaluation of curcumin's effects on α-Syn droplet, oligomer, and fiber formation.
- Assessment of curcumin's impact on α-Syn aggregate toxicity in cell cultures.
- Molecular dynamic simulations of α-Syn fibril-curcumin interactions.
Main Results:
- Curcumin inhibits α-Syn LLPS and subsequent oligomer formation in early aggregation stages.
- Curcumin reduces the toxicity of aggregated α-Syn to cultured cells.
- Van der Waals interactions are key to curcumin's anti-aggregation effect on α-Syn fibrils.
Conclusions:
- Curcumin effectively inhibits Parkinson's disease-related α-Syn aggregation by interfering with early-stage LLPS.
- Understanding these mechanisms provides a basis for developing curcumin-based therapies for PD.
Related Concept Videos
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:58Cooperative Allosteric Transitions
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...